What is Target-Therapy Project?

Lire la suite...

L'info de la semaine

TARGET-THERAPY Plenary Meeting in Brest


Mid-point review of the project (at Year: 2, Quartile: 3) and next plans and timelines Lire la suite...

Key data

Project progression

From April 1, 2021 to March 31, 2024 (36 months in total)



- Researchers

- Postdocs

- PhD students

731 108


Funded by:

- ANR (FR)


2nd French-German call for projects on antimicrobial resistance 2020 “One Health: AMR in environmental reservoirs and colonizing antibiotic resistant bacteria”

The specific objective of this project is to significantly improve the treatment of infections with the WHO priority-1 pathogen P. aeruginosa, which is one of the most dangerous key multi-drug resistant bacteria, inside biofilms in the lungs.

Affiliated institutions